John Hines

Johnson & Johnson (United Kingdom) — United Kingdom

Medicine · Health Sciences

39h-index6.5kcitations186works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(15), Folate and B Vitamins Research(13), Surfactants and Colloidal Systems(13), Acute Myeloid Leukemia Research(12), Infection Control in Healthcare(11)

Publications185 total

Is there is consensus for the aims of aseptic technique undertaken by nurses outside operating theatres? Delphi survey with follow-up study day
Journal of Hospital Infection·2026Open Access
Slave Trading in the Early Middle Ages: long-distance connections in northern and east central Europe. By Janel M Fontaine. 220 mm. Pp xiv + 280, 5 maps. Manchester University Press, Manchester, 2025. <scp>isbn</scp> 9781526160096. £85.00 (hbk).
The Antiquaries Journal·2025
Data from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
2023Open Access
Supplementary Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
Supplementary Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
Supplementary Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
Supplementary Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
Supplementary Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
Supplementary materials and methods from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
2023Open Access
Supplementary materials and methods from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
2023Open Access
Table S1-S7 from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
2023Open Access
Figure S1-S3 from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
2023Open Access
Supplementary Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
Figure S1-S3 from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
2023Open Access
Supplementary Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
Table S1-S7 from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
2023Open Access
Data from The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis
2023Open Access
Supplementary Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
Data from MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Robert K. Thomas(7), R. Kanti(6), David J. Adelstein(6), George Rennie(5), Bercedis L. Peterson(4), Laurence Elias(4), Lois E. Shepherd(4), Richard A. Larson(4), Charles A. Schiffer(4), Peter R. Garrett(4), Frederick R. Appelbaum(3), Jonathan E. Kolitz(3), Vicki A. Morrison(3), J. Penfold(3), Shinichi Kitada(2), Janet Andersen(2), Sophie Akar(2), Juan M. Zapata(2), Shinichi Takayama(2), Stanisław Krajewski(2)